This department is offering a grant to establish Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network. The grant aims to facilitate collaborative multi-center clinical trials focusing on novel treatment approaches and management strategies for hematopoietic stem cell transplantation in both children and adults. The network will prioritize evaluating new HCT approaches, including novel cell therapies, to enhance outcomes and advance the treatment of malignant and non-malignant blood diseases. Applications should aim to improve HCT outcomes, assess innovative cell therapies, and ensure rapid dissemination of study findings to benefit patients requiring HCT therapy. Closing date for applications: November 10, 2016.
Opportunity ID: 287710
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-17-018 |
| Funding Opportunity Title: | Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 19, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 10, 2016 |
| Current Closing Date for Applications: | Nov 10, 2016 |
| Archive Date: | Dec 11, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Private institutions of higher education County governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Native American tribal governments (Federally recognized) State governments City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites applications to participate as a Core Clinical Center/Consortia in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). This collaborative multi-center clinical program promotes the efficient comparison of novel treatment approaches and management strategies for potential benefit of children and adults undergoing hematopoietic stem cell transplantation (HCT), either alone or in combination with novel cell-based therapies. Collaboration among the Core Clinical Centers, the Data Coordinating Center, the NHLBI, the NCI, and other stakeholders will permit multi-center evaluation of new HCT approaches with attention to treatment of malignant and non-malignant blood diseases. During this funding cycle, the BMT CTN will have the flexibility to conduct early phase multi-center HCT trials incorporating novel cell therapies, and to expand the use of promising products from highly selected to more heterogeneous patient populations. The overall goals of the BMT CTN are to improve HCT outcomes, evaluate promising novel cell therapies, and rapidly disseminate study results to improve the scientific basis for the treatment of patients in need of HCT therapy. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00227046 | Oct 10, 2016 | Nov 10, 2016 | View |
Package 1
Mandatory forms
287710 RR_SF424_2_0-2.0.pdf
287710 PHS398_CoverPageSupplement_3_0-3.0.pdf
287710 RR_OtherProjectInfo_1_3-1.3.pdf
287710 PerformanceSite_2_0-2.0.pdf
287710 RR_KeyPersonExpanded_2_0-2.0.pdf
287710 RR_Budget10_1_3-1.3.pdf
287710 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
287710 RR_SubawardBudget10_30_1_3-1.3.pdf
287710 PHS_Inclusion_Enrollment_Report-1.0.pdf
287710 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
